Protein losing enteropathy after Fontan surgery - Clinical and diagnostical aspects

Transfusion Medicine and Hemotherapy

Volumn 34, Issue 3, 2007, Pages 164-167

  Tárnok, Attila ^a   Bocsi, József ^a   Lenz, Dominik ^a   Janousek, Jan ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Elevated fecal alpha1 antitrypsin; Hypoproteinemia; Immunosuppression; Protein losing enteropathy; T lymphocytes; TCPC; Univentricular heart

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; CALCIUM; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN;

ASCITES; CARDIOPULMONARY HEMODYNAMICS; CENTRAL VENOUS PRESSURE; CLINICAL FEATURE; DIARRHEA; FATIGUE; FONTAN PROCEDURE; GROWTH RETARDATION; HEART SINGLE VENTRICLE; HUMAN; HYPOALBUMINEMIA; HYPOPROTEINEMIA; LYMPHANGIECTASIS; LYMPHOCYTOPENIA; MALNUTRITION; PLEURA EFFUSION; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; SURVIVAL RATE; SURVIVAL TIME; WEIGHT REDUCTION;

EID: 34250028158     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101373     Document Type: Review

References (45)

1. Fontan F: Atrio-pulmonary conduit operations for tricuspid atresia and single ventricle. Nippon Kyobu Geka Gakkai Zasshi 1978;26:276-284.
2. Earing MG, Cetta F, Driscoll DJ, Mair DD, Hodge DO, Dearani JA, Puga FJ, Danielson GK, O'Leary PW: Long-term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol 2005;96(2):291-298.
3. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M: Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg 1998;115:1063-1073.
4. Thorne SA, Hooper J, Kemp M, Somerville J: Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease. Eur Heart J 1998;19:514-520.
5. Setty SP, Herrington CS: Fontan procedure: old lessons and new frontiers. Expert Rev Cardiovasc Ther 2006;4(4):515-521.
6. Lenz D, Bocsi J, Hambsch J, Daehnert I, Schneider P, Tárnok A: Chronic inflammation with or without Fontan palliation in univentricular heart patients. Cytometry A 2006;69A(1):57-58.
7. Lenz D, Hambsch J, Schneider P, Hausler HJ, Sauer U, Hess J, Tárnok A: Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? Crit Care 2003;7(2):185-190.
8. Lenz D, Hambsch J, Schneider P, Tárnok A. Protein-losing enteropathy after Fontan surgery: is assessment of risk patients with immunological data possible? Cytometry B Clin Cytom 2003;53B(1):34-39.
9. Tárnok A, Valet GK, Emmrich F: Systems biology and clinical cytomics: The 10th Leipziger Workshop and the 3rd International Workshop on Slide-Based Cytometry, Leipzig, Germany, April 2005. Cytometry A 2006;69A(1):36-40.
10. Bode L, Freeze HH: Applied glycoproteomics - approaches to study genetic-environmental collisions causing protein-losing enteropathy. Biochim Biophys Acta 2006;1760(4):547-59.
11. Shimizu T, Nagata S, Fuji T, Takahashi K, Kishiro M, Okhubo M, Akimoto K, Yamashiro Y: Enhanced production of interferon-gamma as a possible cause of protein-losing enteropathy after modified Fontan operation. J Pediatr Gastroenterol Nutr 2003;37:504-507
12. Ostrow AM, Freeze H, Rychik J: Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 2006;82(2):695-700.
13. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A: Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003;171(11):6164-6172.
14. Bode L, Murch S, Freeze HH: Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem 2006;281(12):7809-7815.
15. Odegard KC, McGowan FX, Zurakowski D, Di-Nardo JA, Castro RA, del Nido PJ, Laussen PC: Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. Ann Thorac Surg 2002;73(6):1770-1777.
16. Westphal V, Murch S, Kim S, Srikrishna G, Winchester B, Day R, Freeze HH: Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. Am J Pathol 2000;157(6):1917-1925.
17. Rychik J, Gui-Yang S: Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am J Cardiol 2002;90(6):672-674.
18. Chaloupecky V, Svobodova I, Hadacova I, Tomek V, Hucin B, Tlaskal T, Janousek J, Reich O, Skovranek J: Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart 2005;91(1):73-79.
19. Koch A, Hofbeck M, Feistel H, Buheitel G, Singer H: Circumscribed intestinal protein loss with deficiency in CD4+ lymphocytes after Fontan procedure. Eur J Pediatr 1999;158:847-850.
20. Cheung YF, Tsang HYF, Kwok JSY: Immunologic profile of patients with protein losing enteropathy complicating congenital heart disease. Pediatr Cardiol 2002;23:587-593.
21. Donnelly JP, Rosenthal A, Castle VP, Holmes RD: Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J Pediatr 1997;130:474-478.
22. Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomao R, Kallas EG, de Moraes-Pinto MI: HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Cytometry B Clin Cytom 2007;72B(1):14-21.
23. Pattanapanyasat K, Shain H, Noulsri E, Lerdwana S, Thepthai C, Prasertsilpa V, Likanonsakul S, Yothipitak P, Nookhai S, Eksaengsri A. A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand. Cytometry B Clin Cytom 2005;65B(1):29-36.
24. Bocsi J, Lenz D, Sauer U, Wild L, Hess J, Schneider P, Hambsch J, Schranz D, Tárnok A: Inflammation and immune suppression following protein losing enteropathy after Fontan surgery detected by cytomics. Transfus Med Hemother 2007;34(3):168-175.
25. Brawura-Biskupski-Samaha R, Grzela T: Autoimmune lymphoproliferative syndrome-impaired regulation of the immune response by impaired induction of apoptosis. Transfus Med Hemother 2006:33(1):71-79.
26. Sack U, Gerling F, Tárnok A: Age related lymphocyte subset changes in the peripheral blood of healthy children. A meta-study. Transfus Med Hemother 2007;34(3):176-181.
27. Tárnok A, Schneider P: Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression. Shock 2001;16(suppl 1):24-32.
28. Petrausch U, Haley D, Miller W, Floyd K, Urba WJ, Walker E: Polychromatic flow cytometry: a rapid method for the reduction and analysis of complex multiparameter data. Cytometry A 2006;69A(12):1162-73.
29. Mittag A, Lenz D, Gerstner AO, Tárnok A. Hyperchromatic cytometry principles for cytomics using slide based cytometry. Cytometry A 2006;69A(7):691-703.
30. Shapiro HM, Perlmutter NG: Personal cytometers: slow flow or no flow? Cytometry A 2006;69A(7):620-30.
31. Barten MJ, Rahmel A, Bocsi J, Boldt A, Garbade J, Dhein S, Mohr FW, Gummert JF: Cytokine analysis to predict immunosuppression. Cytometry A 2006;69A(3):155-157.
32. Gille C, Orlikowsky T: Flow cytometric methods in the detection of neonatal infection. Transfus Med Hemother 2007;34(3):157-163.
33. Schlenke P: Leukocyte reduction in blood component supply: the impact of flow cytometry in assessing residual leukocytes. Transfus Med Hemother 2005:32(1):12-19.
34. Stahl D: Current concepts on immune regulation: impact on scientific and clinical aspects of immunohematology Transfus Med Hemother 2005;32(6):293-295.
35. Sack U, Scheibe R, Wotzel M, Hammerschmidt S, Kuhn H, Emmrich F, Hoheisel G, Wirtz H, Gessner C: Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A 2006;69A(3):169-172.
36. Laffers W, Schlenkhoff C, Kristina Pieper K, Mittag M, Tárnok A, Gerstner AOH. Concepts for absolute immunophenosubtyping by slide-based cytometry. Transfus Med Hemother 2007;34(3):188-194.
37. Bocsi J, Richter M, Hambsch J, Barten MJ, Dahnert I, Schneider P, Tárnok A. Transient Th1/Th2 disbalance indicates postoperative effusions and edema after cardiopulmonary bypass in children. Cytometry A 2006;69A(3):165-168.
38. Hasskarl H: Zur Zulässigkeit der Umsetzung der EG-Blutrichtlinien 2002/98/EG und 2004/33/EG in nationales Recht durch Richtlinien der Bundesärztekammer nach §§ 12 und 18 Transfusionsgesetz. Transfus Med Hemother 2005;32:34-41.
39. Rychik J, Spray TL: Strategies to treat protein-losing enteropathy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002;5:3-11.
40. Pötzsch B, Müller J, Rox JM: Developmental strategies of novel anticoagulants. Transfus Med Hemother 2006;33(2):200-204.
41. Hosseinpour AR, Cullen S, Tsang VT: Transplantation for adults with congenital heart disease. Eur J Cardiothorac Surg 2006;30(3):508-514.
42. Tárnok A, Bocsi J, Brockhoff G: Cytomics - importance of multimodal analysis of cell function and proliferation in oncology. Cell Prolif 2006;39(6):495-505.
43. Valet G: Human cytome project, cytomics, and systems biology: the incentive for new horizons in cytometry. Cytometry A 2005;64A(1):1-2.
44. Lenz D, Barten MJ, Hiller S, Tárnok A, Sack U: Regenerative and predictive medicine of cardiovascular disease: the 9th Leipziger Workshop and the 2nd International Workshop on slide based cytometry. Cytometry A 2005;64A(2):110-114.
45. Valet G: Diagnostic versus predictive flow cytometry. Lab Hematol 2004;10(3):166-168.